Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal

NCT00106106 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.

NCT NCT00106106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00106106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Acamprosate for Central Nervous System Hyperexcitability and Neuroadaptation in Alcohol Withdrawal
Lead sponsor
National Institutes of Health Clinical Center (CC)
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2005
Completion date
July 31, 2010
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, alcohol-related disorders, alcoholism, healthy volunteer